Case Study: Stabilising Radiochemistry Through Flow‑Enabled Isotope Labelling

A US biopharmaceutical company was seeking to improve the stability of their chemically unstable API intermediate for radiochemical trials. Our experts were able to reduce degradation through flow processing and successful ¹⁴C synthesis was achieved to support both non-clinical and clinical trials.

Download a copy of our case study: Stabilising Radiochemistry Through Flow‑Enabled Isotope Labelling today.